{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:11:38Z","timestamp":1649178698869},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T00:00:00Z","timestamp":1386201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s12928-013-0229-1","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T08:31:11Z","timestamp":1386145871000},"page":"123-133","source":"Crossref","is-referenced-by-count":2,"title":["Japanese postmarketing surveillance of clopidogrel for patients with non-ST-segment-elevation acute coronary syndrome indicated for percutaneous coronary intervention (J-PLACE NSTE-ACS)"],"prefix":"10.1007","volume":"29","author":[{"given":"Yoshihiro","family":"Morino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Ako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,5]]},"reference":[{"key":"229_CR1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494\u2013502.","journal-title":"N Engl J Med"},{"key":"229_CR2","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","volume":"366","author":"ZM Chen","year":"2005","unstructured":"Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction trial) Collaborative Group, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1607\u201321.","journal-title":"Lancet"},{"key":"229_CR3","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","volume":"110","author":"KAA Fox","year":"2004","unstructured":"Fox KAA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST elevation acute coronary syndrome: the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) trial. Circulation. 2004;110:1202\u20138.","journal-title":"Circulation"},{"key":"229_CR4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","volume":"352","author":"M Sabatine","year":"2005","unstructured":"Sabatine M, Cannon C, Gibson C, Lopez-Sendon J, Montalescot G, Theroux P, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179\u201389.","journal-title":"N Engl J Med"},{"key":"229_CR5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Butaji A, Cannon CP, Emanuelsson H, Held C, For the PLATO Investigators, et al. Ticagrelol versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045\u201357.","journal-title":"N Engl J Med"},{"key":"229_CR6","first-page":"2473","volume":"124","author":"SC Smith Jr","year":"2011","unstructured":"Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2473\u201385.","journal-title":"Circulation"},{"key":"229_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","volume":"117","author":"SB King III","year":"2008","unstructured":"King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. Writing Group to review new evidence and update the ADD\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, writing on behalf of the 2005 Writing Committee. 2007 focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guideline. Circulation. 2008;117:261\u201395.","journal-title":"Circulation"},{"key":"229_CR8","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.CIR.99.18.2364","volume":"99","author":"I Maussa","year":"1999","unstructured":"Maussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation. 1999;99:2364\u20136.","journal-title":"Circulation"},{"key":"229_CR9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","volume":"102","author":"ME Brertrand","year":"2000","unstructured":"Brertrand ME, Rupprecht H-J, Urban P, Gershlick AH, For the CLASSICS Investigators. Double-blind study of the safety of clopidogrel with or without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS). Circulation. 2000;102:624\u20139.","journal-title":"Circulation"},{"key":"229_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2369-14-107","volume":"14","author":"MJ Fischer","year":"2013","unstructured":"Fischer MJ, Ho PM, McDermott K, Lowy E, Parikh CR. Chronic kidney disease is associated with adverse outcomes among elderly patients taking clopidogrel after hospitalization for acute coronary syndrome. BMC Nephrol. 2013;14:107.","journal-title":"BMC Nephrol"},{"key":"229_CR11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-156-6-201203200-00007","volume":"156","author":"SC Palmer","year":"2012","unstructured":"Palmer SC, Di Micco L, Razavian M, Craig JC, Perkovic V, Pellegrini F, et al. Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;156:445\u201359.","journal-title":"Ann Intern Med"},{"key":"229_CR12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.hjr.0000220582.19516.a6","volume":"14","author":"M Keltai","year":"2007","unstructured":"Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, et al. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. Eur J Cardiovasc Prev Rehabil. 2007;14:312\u20138.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"229_CR13","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2011.08.051","volume":"58","author":"SS Basra","year":"2011","unstructured":"Basra SS, Tsai P, Lakkis NM. Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease. J Am Coll Cardiol. 2011;58:2263\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"229_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ahj.2007.10.046","volume":"155","author":"PJ Best","year":"2008","unstructured":"Best PJ, Steinhubl SR, Berger PB, Dasgupta A, Brennan DM, Szczech LA, et al. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am Heart J. 2008;155:687\u201393.","journal-title":"Am Heart J"},{"key":"229_CR15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"CS Fox","year":"2010","unstructured":"Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation. 2010;121:357\u201365.","journal-title":"Circulation"},{"key":"229_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1472-8206.2010.00915.x","volume":"26","author":"G Cadiou","year":"2012","unstructured":"Cadiou G, Adam M, Caussin M, Landrin I, Mariette N, Capet C, et al. Antiplatelet drugs in the elderly: prescriptions often inappropriate and reduced tolerance by associated diseases and drugs. Fundam Clin Pharmacol. 2012;26:307\u201313.","journal-title":"Fundam Clin Pharmacol"},{"key":"229_CR17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","volume":"381","author":"WJ Dewilde","year":"2013","unstructured":"Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman JP, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381:1107\u201315.","journal-title":"Lancet"},{"key":"229_CR18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4244\/EIJV8I6A105","volume":"8","author":"JG Smith","year":"2012","unstructured":"Smith JG, Wieloch M, Koul S, Braun O\u00d6, Lumsden J, Rydell E, et al. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score. EuroIntervention. 2012;8:672\u20138.","journal-title":"EuroIntervention"},{"key":"229_CR19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","volume":"301","author":"PM Ho","year":"2009","unstructured":"Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301:937\u201344.","journal-title":"JAMA"},{"key":"229_CR20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","volume":"180","author":"DN Juurlink","year":"2009","unstructured":"Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. Can Med Assoc J. 2009;180:713\u20138.","journal-title":"Can Med Assoc J"},{"key":"229_CR21","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.amjcard.2010.01.348","volume":"105","author":"CC Huang","year":"2010","unstructured":"Huang CC, Chen YC, Leu HB, Chen TJ, Lin SJ, Chan WL, et al. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention. Am J Cardiol. 2010;105:1705\u20139.","journal-title":"Am J Cardiol"},{"key":"229_CR22","unstructured":"Food and Drug Administration. Drug safety communication: Reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm203888.htm (Accessed 13 Aug 2013)."},{"key":"229_CR23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12928-011-0063-2","volume":"26","author":"T Kimura","year":"2011","unstructured":"Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, et al. Association of the use of proton pump inhibitors with adverse cardiovascular and bleeding outcomes after percutaneous coronary intervention in the Japanese real world clinical practice. Cardiovasc Interv Ther. 2011;26:222\u201333.","journal-title":"Cardiovasc Interv Ther"},{"key":"229_CR24","doi-asserted-by":"crossref","unstructured":"Jiang Z, Wu H, Duan Z, Wang Z, Hu K, Ye F, et al. Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention. Clin Res Hepatol Gastroenterol. 2013 (Epub ahead of print).","DOI":"10.1016\/j.clinre.2013.03.011"},{"key":"229_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12928-010-0031-2","volume":"26","author":"K Ohkubo","year":"2011","unstructured":"Ohkubo K, Kobayashi Y, Nakamura Y, Miyazaki A. Incidence of side-effects of dual antiplatelet therapy with clopidogrel and aspirin after coronary stent implantation. Cardiovasc Interv Ther. 2011;26:33\u20137.","journal-title":"Cardiovasc Interv Ther"},{"key":"229_CR26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1536\/ihj.53.91","volume":"53","author":"T Isshiki","year":"2012","unstructured":"Isshiki T, Kimura T, Ueno T, Nakamura M, Igarashi K, Yokoi H, et al. Clopidogrel trial in patients with elective percutaneous coronary intervention for stable angina and old myocardial infarction (CLEAN): safety and efficacy study of clopidogrel compared to ticlopidine in Japanese patients. Int Heart J. 2012;53:91\u2013101.","journal-title":"Int Heart J"},{"key":"229_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000111498","volume":"25","author":"Y Fukuuchi","year":"2008","unstructured":"Fukuuchi Y, Tohgi H, Okudera T, Ikeda Y, Miyanaga Y, Uchiyama S, et al. A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction. Cerebrovasc Dis. 2008;25:40\u20139.","journal-title":"Cerebrovasc Dis"},{"key":"229_CR28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00415-009-5035-4","volume":"256","author":"S Uchiyama","year":"2009","unstructured":"Uchiyama S, Fukuuchi Y, Yamaguchi T. The safety and efficacy of clopidogrel versus ticlopidine in Japanese stroke patients: combined results of two phase III, multicenter, randomized clinical trials. J Neurol. 2009;256:888\u201397.","journal-title":"J Neurol"},{"key":"229_CR29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3400\/avd.oa.12.00039","volume":"5","author":"H Shigematsu","year":"2012","unstructured":"Shigematsu H, Komori K, Tanemoto K, Harada Y, Nakamura M. Clopidogrel for atherothrombotic event management in patients with peripheral arterial disease (COOPER) study: safety and efficacy of clopidogrel versus ticlopidine in Japanese patients. Ann Vasc Dis. 2012;5:364\u201375.","journal-title":"Ann Vasc Dis"},{"key":"229_CR30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1253\/circj.CJ-13-0174","volume":"77","author":"H Daida","year":"2013","unstructured":"Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, et al. Management and two-year long-term clinical outcomes of patients with acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J. 2013;77:934\u201343.","journal-title":"Circ J"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-013-0229-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12928-013-0229-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-013-0229-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T11:48:42Z","timestamp":1564919322000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12928-013-0229-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["229"],"URL":"https:\/\/doi.org\/10.1007\/s12928-013-0229-1","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,5]]}}}